Under construction – not a live service
Sign in
Taking people in ChinaNo phase

Comparing Soft and Rigid Settings on a Knee Training Robot in Children With SMA

Compares two knee robot settings for leg muscle training in children with spinal muscular atrophy.

Plain-language title generated from the registry record
Registry title: Effects of Different Stiffness Settings During Robotic Isokinetic Training in Children With SMA

Key facts

Where
Beijing, ChinaSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 6 and 12 years old?

Source: NCT07822711, who can take part

Where in China

  • Peking University Third HospitalBeijing, ChinaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Peking University Third Hospital
Trial code
NCT07822711
Record updated
23 October 2026
Original description
This randomized, within-participant, contralateral-limb-controlled clinical trial will compare individually optimized compliant and rigid stiffness settings of a portable isokinetic knee training robot in children with spinal muscular atrophy. At least 13 children aged 6 to 12 years will be enrolled. For each participant, one leg will be randomly assigned to the compliant setting and the contralateral leg to the rigid setting using sequentially numbered, opaque, sealed envelopes. Both legs will receive the same training volume, number of repetitions, and angular velocity for up to 8 weeks. The primary outcome is the between-setting difference in the change from baseline in peak isokinetic knee-extension torque. Secondary outcomes include knee-extension range of motion, quadriceps cross-sectional area on magnetic resonance imaging, femoral nerve conduction measures, and sit-to-stand performance. Knee pain, suprapatellar skin temperature, fatigue, and other adverse events will be monitored throughout the study.Read full original descriptionShow less

Effects of Different Stiffness Settings on Isokinetic Quadriceps Training in Children With Spinal Muscular Atrophy: A Randomized Within-Participant, Contralateral-Limb-Controlled Trial

This randomized, within-participant, contralateral-limb-controlled clinical trial will compare individually optimized compliant and rigid stiffness settings of a portable isokinetic knee training robot in children with spinal muscular atrophy. At least 13 children aged 6 to 12 years will be enrolled. For each participant, one leg will be randomly assigned to the compliant setting and the contralateral leg to the rigid setting using sequentially numbered, opaque, sealed envelopes. Both legs will receive the same training volume, number of repetitions, and angular velocity for up to 8 weeks. The primary outcome is the between-setting difference in the change from baseline in peak isokinetic knee-extension torque. Secondary outcomes include knee-extension range of motion, quadriceps cross-sectional area on magnetic resonance imaging, femoral nerve conduction measures, and sit-to-stand performance. Knee pain, suprapatellar skin temperature, fatigue, and other adverse events will be monitored throughout the study.

Inclusion: Age 6 to 12 years; Diagnosis of spinal muscular atrophy; Able to maintain an independent seated position; If receiving disease-modifying treatment, including nusinersen or risdiplam, the participant must have received a stable dose for at least 6 months before enrollment and must not change the treatment regimen during the study.

Exclusion: Any other major disease or medical condition that, in the investigator's judgment, would interfere with safe participation or interpretation of the study results; Blood pressure above the 95th percentile for age, sex, and height, as assessed by a clinician; The legal guardian declines to provide written informed consent, or the participant is unable to complete the study procedures; Unable to undergo magnetic resonance imaging or electromyography and nerve conduction testing; Lacks the cognitive capacity to understand or comply with the requirements of study participation.

ClinicalTrials.gov NCT07822711